Comparison of different agents and doses of anti-vascular endothelial growth factors (aflibercept, bevacizumab, conbercept, ranibizumab) versus laser for retinopathy of prematurity: A network meta-analysis.

Avastin (bevacizumab) - Roche

Lucentis (ranibizumab) - Roche, Novartis

Lumitin (conbercept) - Chengdu Kanghong Pharma

http://www.ncbi.nlm.nih.gov/pubmed/38432359

Amparo Ortiz-Seller; Esteban Morcillo; Honorio Barranco; Isabel Pascual-Camps; José L Ortiz; Pablo Martorell

Mar 4, 2024